13F Holdings
中文EN

NTR Nutrien Ltd. IFRS Annual reports only

Agricultural Chemicals · NYSE · SEC CIK 1725964 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY3.5%
TTM net income YoY236.4%
TTM EPS YoY242.6%
Revenue 3-yr CAGR-10.8%
Net income 3-yr CAGR-33.4%

Margins

Gross margin31.0%
Operating margin13.9%
Net margin8.4%
FCF margin7.9%
EBITDA margin22.7%

Returns

ROE9.1%
ROA4.4%
ROIC (approx.)8.2%
Asset turnover0.52x

Leverage & solvency

Liabilities / assets51.5%
Debt / equity0.40x
Current ratio1.34x
Interest coverage5.01x

Cash quality & payout

Operating cash flow / net income1.77x
Accruals ratio-3.3%
Payout ratio46.8%
Capex / revenue7.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$26.89B$25.97B$29.06B$37.88B$27.71B
Cost of revenue$17.60B$17.49B$19.61B$21.59B$17.45B
Gross profit$8.35B$7.53B$8.47B$15.42B$9.41B
SG&A expense$600.00M$644.00M$626.00M$565.00M$477.00M
Operating income$3.74B$1.86B$2.75B$10.81B$4.78B
Interest expense$746.00M$765.00M$797.00M$521.00M$492.00M
Pretax income$3.05B$1.14B$1.95B$10.25B$4.17B
Income tax$752.00M$436.00M$670.00M$2.56B$989.00M
Net income$2.27B$674.00M$1.26B$7.66B$3.15B
EBITDA$6.11B$4.20B$4.91B$12.82B$6.73B
EPS (basic)4.661.362.5314.225.53
EPS (diluted)4.661.362.5314.185.52
Dividends declared per share—2.162.121.92—
Weighted avg. shares (diluted)486.52M494.37M496.99M540.01M571.29M
Balance sheet
Cash & equivalents$701.00M$853.00M$941.00M$901.00M$499.00M
Receivables$5.67B$5.39B$5.40B$6.19B$5.37B
Inventory$6.98B$6.15B$6.34B$7.63B$6.33B
Current assets$14.75B$13.79B$14.17B$16.34B$13.85B
PP&E, netmay include right-of-use assets (IFRS)$22.75B$22.60B$22.46B$21.77B$20.02B
Goodwill$12.14B$12.04B$12.11B$12.37B$12.22B
Intangibles$1.67B$1.82B$2.22B$2.30B$2.34B
Total assets$52.30B$51.84B$52.75B$54.59B$49.95B
Current liabilities$11.04B$12.04B$12.12B$14.28B$12.44B
Short-term debt$873.00M$1.53B$1.81B$2.14B$1.56B
Long-term debt$9.35B$8.88B$8.91B$8.04B$7.52B
Total debt$10.22B$10.41B$10.73B$10.18B$9.08B
Total liabilities$26.94B$27.40B$27.55B$28.72B$26.25B
Shareholders' equity$25.32B$24.41B$25.16B$25.82B$23.65B
Net debt$9.52B$9.56B$9.79B$9.28B$8.58B
Shares outstanding—491.03M494.55M507.25M557.49M
Cash flow statement
Operating cash flow$4.01B$3.54B$5.07B$8.11B$3.89B
Capital expenditure$1.88B$2.02B$2.42B$2.25B$1.78B
Free cash flow$2.12B$1.51B$2.65B$5.86B$2.11B
Investing cash flow-$1.37B-$2.13B-$2.96B-$2.90B-$1.81B
Financing cash flow-$2.82B-$1.45B-$2.06B-$4.73B-$3.00B
Depreciation & amortization$2.37B$2.34B$2.17B$2.01B$1.95B
Stock-based compensation$163.00M$37.00M-$14.00M$63.00M$198.00M
Dividends paid$1.06B$1.06B$1.03B$1.03B$1.04B
Share buybacks$551.00M$184.00M$1.05B$4.52B$1.03B

Free plan shows the latest 5 periods; Pro shows all 9 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.